CN104771580A - Traditional Chinese medicine composition for treating prostatitis - Google Patents
Traditional Chinese medicine composition for treating prostatitis Download PDFInfo
- Publication number
- CN104771580A CN104771580A CN201510110759.XA CN201510110759A CN104771580A CN 104771580 A CN104771580 A CN 104771580A CN 201510110759 A CN201510110759 A CN 201510110759A CN 104771580 A CN104771580 A CN 104771580A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine composition for treating prostatitis. The composition is composed of the following raw materials in parts by weight: 11 to 12 parts of gentrin knotweed, 5 to 6 parts of oriental water plantain rhizome, 8 to 10 parts of dandelion, 4 to 5 parts of rhizoma corydalis, 2 to 4 parts of toosendan fruit, 6 to 8 parts of cowherb seed, 4 to 6 parts of tuber of dwarf lilyturf, 1 to 3 parts of teasel root, 6 to 7 parts of achyranthes root, 3 to 5 parts of pseudostellaria root, 7 to 8 parts of pleione bulbocodioides, 4 to 5 parts of ligusticum wallichii, 2 to 4 parts of red sage root, 6 to 8 parts of euphorbia kansui, 1 to 3 parts of vinegar-processed corydalis tuber, 3 to 5 parts of oyster, 5 to 7 parts of plantain, 4 to 5 parts of Chinese starjasmine stem, 2 to 4 parts of fleece flower stem, 1 to 3 parts of pondweed root, and 2 to 4 parts of hylomecon japonica. The provided composition has the functions of activating blood circulation to remove blood stasis, clearing heat, removing dampness, tonifying middle-Jiao and qi, elevating clear qi to lower turbid qi, nourishing yin in kidney, and warming and invigorating kidney yang, contains traditional Chinese herbals capable of nourishing yin and tonifying kidney, and has a good curative effect on treating prostatitis patients. The effective rate of the traditional Chinese medicine composition can reach 95.8%.
Description
Technical field
The present invention relates to one and treat prostatitic Chinese medicine composition, belong to the field of Chinese medicines.
Background technology
The prostatitis active chronic inflammation that to be a kind of be caused by prostate specific and non-specific infection, the hyperemia mainly caused due to various different reason and infected by microbes cause, the generation of the series of symptoms such as frequent micturition, urgent micturition, dysurea can be produced, cause the appearance of male sexual disorder and some serious symptoms such as sterile, if can not get effective treatment for a long time, the state of an illness is often made to produce canceration; Clinical treatment has multiple method, doctor trained in Western medicine mainly by taking antibiotic therapy, to prostatic hyperplasia still based on operative treatment, in addition, also coordinate topical therapeutic, the traditional Chinese medical science to prostatitis and prostatic hyperplasia mainly based on determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, Chinese medicine for oral administration, but curative effect is not clearly, takes effect slow.
Summary of the invention
One is the object of the present invention is to provide to treat prostatitic Chinese medicine composition.
The present invention adopts following technical scheme to achieve these goals:
Treat prostatitic Chinese medicine composition, the weight portion of its constitutive material is: Rhizoma Polygoni Cuspidati 11-12, Rhizoma Alismatis 5-6, Herba Taraxaci 8-10, Rhizoma Corydalis 4-5, Fructus Toosendan 2-4, Semen Vaccariae 6-8, Radix Ophiopogonis 4-6, Radix Dipsaci 1-3, Radix Achyranthis Bidentatae 6-7, Radix Pseudostellariae 3-5, Pseudobulbus Cremastrae Seu Pleiones 7-8, Rhizoma Chuanxiong 4-5, Radix Salviae Miltiorrhizae 2-4, Radix Kansui 6-8, Rhizoma Corydalis (processed with vinegar) 1-3, Concha Ostreae 3-5, Herba Plantaginis 5-7, Caulis Trachelospermi 4-5, Caulis Polygoni Multiflori 2-4, Herba potamogetonis distincti root 1-3 and Radix Hylomeci japonicae 2-4.
Treat prostatitic Chinese medicine composition, the weight portion of its constitutive material is: Rhizoma Polygoni Cuspidati 12, Rhizoma Alismatis 5.5, Herba Taraxaci 9, Rhizoma Corydalis 4.5, Fructus Toosendan 3, Semen Vaccariae 7, Radix Ophiopogonis 5, Radix Dipsaci 2, Radix Achyranthis Bidentatae 6.5, Radix Pseudostellariae 4, Pseudobulbus Cremastrae Seu Pleiones 7.5, Rhizoma Chuanxiong 4.5, Radix Salviae Miltiorrhizae 3, Radix Kansui 7, Rhizoma Corydalis (processed with vinegar) 2, Concha Ostreae 4, Herba Plantaginis 6, Caulis Trachelospermi 4.5, Caulis Polygoni Multiflori 3, Herba potamogetonis distincti's root 2 and Radix Hylomeci japonicae 3.
Herba potamogetonis distincti's root is tender of Potamogetonaceae plant Herba potamogetonis distincti, and Radix Hylomeci japonicae is the root of bloodroot Radix Hylomeci japonicae.
Consumption and usage: take Chinese medicine composition of the present invention, every day potion, within 20 days, be a course for the treatment of, general 3-4 can cure a course for the treatment of.
Beneficial effect of the present invention:
Medicine of the present invention has effect of blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, invigorating the spleen and replenishing QI, ascending the clear and descending the turbid, nourishing kidney yin and warming and recuperating the kidney-YANG, coordinate the Chinese medicinal components such as enriching yin and nourishing kidney, have good curative effect for treatment prostatitis patient, total effective rate of the present invention reaches 95.8%.
Detailed description of the invention
Embodiment 1: treat prostatitic Chinese medicine composition, the weight portion (g) of its constitutive material is: Rhizoma Polygoni Cuspidati 12, Rhizoma Alismatis 5.5, Herba Taraxaci 9, Rhizoma Corydalis 4.5, Fructus Toosendan 3, Semen Vaccariae 7, Radix Ophiopogonis 5, Radix Dipsaci 2, Radix Achyranthis Bidentatae 6.5, Radix Pseudostellariae 4, Pseudobulbus Cremastrae Seu Pleiones 7.5, Rhizoma Chuanxiong 4.5, Radix Salviae Miltiorrhizae 3, Radix Kansui 7, Rhizoma Corydalis (processed with vinegar) 2, Concha Ostreae 4, Herba Plantaginis 6, Caulis Trachelospermi 4.5, Caulis Polygoni Multiflori 3, Herba potamogetonis distincti's root 2 and Radix Hylomeci japonicae 3.
Consumption and usage: take Chinese medicine composition of the present invention, every day potion, within 20 days, be a course for the treatment of, general 3-4 can cure a course for the treatment of.
Model case:
Case 1: Fu, man, 37 years old, suffer from more than three years of chronic prostatitis, with shiver with cold, heating, the General Symptomies such as fatigue and weak, hyposexuality, premature ejaculation, take Chinese medicine composition of the present invention, every day potion, after taking two courses for the treatment of, premature ejaculation symptom is clearly better, continue to take two courses for the treatment of with consolidate curative effect, all malaise symptoms disappear completely, cure.
Case 2: Hu, man, 49 years old, often feel urine urgency-frequency urine retention in this year, body feels weak, with the symptom such as sexual impotence, premature ejaculation, be prostatitis to hospital diagnosis, take Chinese medicine composition of the present invention, every day potion, after taking one month, frequent micturition, symptoms of urgency are alleviated, continue to take two courses for the treatment of, cure, all malaise symptoms disappear.
Case 3: permitted certain, man, 43 years old, long-term urine urgency-frequency, with symptoms such as painful ejaculation, sexual impotence, premature ejaculation, checks and is diagnosed as prostatitis, multi-treatment is invalid, after take Chinese medicine composition of the present invention, every day, potion, serve on four courses for the treatment of, all diseases disappear entirely, cure, rear continuation takes a course for the treatment of with consolidate curative effect, does not recur so far.
Claims (2)
1. treat a prostatitic Chinese medicine composition, it is characterized in that the weight portion of its constitutive material is: Rhizoma Polygoni Cuspidati 11-12, Rhizoma Alismatis 5-6, Herba Taraxaci 8-10, Rhizoma Corydalis 4-5, Fructus Toosendan 2-4, Semen Vaccariae 6-8, Radix Ophiopogonis 4-6, Radix Dipsaci 1-3, Radix Achyranthis Bidentatae 6-7, Radix Pseudostellariae 3-5, Pseudobulbus Cremastrae Seu Pleiones 7-8, Rhizoma Chuanxiong 4-5, Radix Salviae Miltiorrhizae 2-4, Radix Kansui 6-8, Rhizoma Corydalis (processed with vinegar) 1-3, Concha Ostreae 3-5, Herba Plantaginis 5-7, Caulis Trachelospermi 4-5, Caulis Polygoni Multiflori 2-4, Herba potamogetonis distincti root 1-3 and Radix Hylomeci japonicae 2-4.
2. the prostatitic Chinese medicine composition for the treatment of according to claim 1, is characterized in that the weight portion of its constitutive material is: Rhizoma Polygoni Cuspidati 12, Rhizoma Alismatis 5.5, Herba Taraxaci 9, Rhizoma Corydalis 4.5, Fructus Toosendan 3, Semen Vaccariae 7, Radix Ophiopogonis 5, Radix Dipsaci 2, Radix Achyranthis Bidentatae 6.5, Radix Pseudostellariae 4, Pseudobulbus Cremastrae Seu Pleiones 7.5, Rhizoma Chuanxiong 4.5, Radix Salviae Miltiorrhizae 3, Radix Kansui 7, Rhizoma Corydalis (processed with vinegar) 2, Concha Ostreae 4, Herba Plantaginis 6, Caulis Trachelospermi 4.5, Caulis Polygoni Multiflori 3, Herba potamogetonis distincti's root 2 and Radix Hylomeci japonicae 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510110759.XA CN104771580A (en) | 2015-03-14 | 2015-03-14 | Traditional Chinese medicine composition for treating prostatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510110759.XA CN104771580A (en) | 2015-03-14 | 2015-03-14 | Traditional Chinese medicine composition for treating prostatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104771580A true CN104771580A (en) | 2015-07-15 |
Family
ID=53613563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510110759.XA Pending CN104771580A (en) | 2015-03-14 | 2015-03-14 | Traditional Chinese medicine composition for treating prostatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104771580A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250707A (en) * | 2015-11-13 | 2016-01-20 | 刘心元 | Traditional Chinese medicine composition for treatment of middle qi insufficiency type chronic prostatitis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638206A (en) * | 2013-11-26 | 2014-03-19 | 隗存富 | Traditional Chinese medicine formula for treating acute prostatitis |
-
2015
- 2015-03-14 CN CN201510110759.XA patent/CN104771580A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638206A (en) * | 2013-11-26 | 2014-03-19 | 隗存富 | Traditional Chinese medicine formula for treating acute prostatitis |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250707A (en) * | 2015-11-13 | 2016-01-20 | 刘心元 | Traditional Chinese medicine composition for treatment of middle qi insufficiency type chronic prostatitis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100364589C (en) | A Chinese medicine for treating psoriasis | |
CN101327298B (en) | Chinese medicine for treating pruritus dermatopathy | |
CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
CN101422554A (en) | Traditional Chinese medicine for treating acne | |
CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
CN101229337B (en) | Chinese traditional medicine for treating bronchitis and bronchial asthma | |
CN103099882B (en) | Traditional Chinese medicine composition for treating liver qi-stagnation type hyperplasia of mammary glands | |
CN104771580A (en) | Traditional Chinese medicine composition for treating prostatitis | |
CN103463560B (en) | Traditional Chinese medicine composition for treating rosacea | |
CN102078432A (en) | Medicament for treating skin itch | |
CN106075265A (en) | The Chinese medicine composition for the treatment of viral influenza | |
CN105106837A (en) | Traditional Chinese medicine combination for treating viral hepatitis | |
CN101700343A (en) | Traditional Chinese medicine for treating prostatitis | |
CN104922410A (en) | TCM (traditional Chinese medicine) preparation for treating porcine circovirus disease | |
CN103330803A (en) | Chinese medicinal composition for vasculitis | |
CN101249250A (en) | Medicinal liquor preparations for curing stagnation and blood stasis chest stuffiness and pain | |
CN106039236A (en) | Traditional Chinese medicine preparation for treating bone cancer and improving immunity, and preparation method of traditional Chinese medicine preparation | |
CN1382486A (en) | Fengshitongluo wan for treating rheumatism | |
CN106668390B (en) | Traditional Chinese medicine composition for treating hyperthyroidism in early and middle stages | |
CN105288511A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis and preparation method thereof | |
CN105963630A (en) | Traditional Chinese medicine composition for treating prostatitis | |
CN104758567A (en) | Traditional Chinese medicine for treating angiitis | |
CN104922443A (en) | External-use patch for treating rheumatic arthritis | |
CN104888102A (en) | Traditional Chinese medicine decoction for treating cholecystitis | |
CN101703664B (en) | Chinese medicinal composition for treating hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150715 |